Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Retigabine effects on cortical excitability
NCT01823159Phase 3Completed
- Sponsor
- CHU UCL Namur - site Godinne
- Start
- Apr 2013
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of retigabine in epilepsy, sponsored by CHU UCL Namur - site Godinne. Started Apr 2013; status: completed.
02
Drugs
retigabine
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT01823159.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01823159.